| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/03/2005 | CN1213144C Recombination nucleic acid molecule and application thereof |
| 08/03/2005 | CN1213143C Pharmacentical use of homoeotic hematoietic system reconstitution cell |
| 08/03/2005 | CN1213070C Monoclonal antibodies directed against the G3BP protein and use |
| 08/03/2005 | CN1212866C Biodegradable polymer scaffold structure |
| 08/02/2005 | USRE38768 Inbred corn line G1900 |
| 08/02/2005 | US6924421 Hybrid maize plant and seed 34D71 |
| 08/02/2005 | US6924414 Muir-torre-like syndrome in Fhit deficient mice |
| 08/02/2005 | US6924357 Polypeptide encoded by a polynucleotide of given sequence; detecting the effect of a test compound on the production of mRNA; use in identifying agonists/antagonists that may be useful in therapy |
| 08/02/2005 | US6924356 Human protein HHEPU32 |
| 08/02/2005 | US6924144 Method and means for producing high titer, safe, recombinant lentivirus vectors |
| 08/02/2005 | US6924143 Method for increasing the growth rate of cells in static liquid media |
| 08/02/2005 | US6924142 Multipotent neural stem cells are proliferated in the presence of growth factors and erythropoietin which induces the generation of neuronal progenitor cells |
| 08/02/2005 | US6924141 Inducing the effects of promoted signal transduction with protein and lithium chloride or mimicking via administration of agent that inhibits either catenin phosphorylation or kinase |
| 08/02/2005 | US6924128 Packaging cell lines for generation of high titers of recombinant AAV vectors |
| 08/02/2005 | US6924126 Cloning, expression and characterization of the SPG4 gene responsible for the most frequent form of autosomal spastic paraplegia |
| 08/02/2005 | US6924124 Feeding strategies for cell culture |
| 08/02/2005 | US6924123 Transducting, dividing cells; gene expression; gene therapy |
| 08/02/2005 | US6924121 Sperm specific proteins |
| 08/02/2005 | US6924120 sequence linked to a target protein, preferably an insulin precursor; present invention also relates to a process for obtaining a correctly folded insulin-precursor |
| 08/02/2005 | US6924119 cGMP-visualizing probe and a method of detecting and quantifying of cGMP by using the same |
| 08/02/2005 | US6924117 Human RRP sequences and methods of use |
| 08/02/2005 | US6924110 NPHS2 gene involved in the steroid-resistant nephrotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses |
| 08/02/2005 | US6924095 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma |
| 08/02/2005 | US6923993 Process of isolating extract from the Euphorbia obesa plant and methods for using the same |
| 08/02/2005 | US6923969 Nucleotide sequences coding viral protein for use in vaccinations and veterinary medicine |
| 08/02/2005 | US6923959 Method of pre-inducing a state of immune tolerance before organ transplantation |
| 08/02/2005 | CA2406391C Normalized nucleic acid libraries and methods of production thereof |
| 08/02/2005 | CA2343586C Modified green fluorescent proteins |
| 08/02/2005 | CA2148934C Targetable vector particles |
| 08/02/2005 | CA2078539C Process for producing humanized chimera antibody |
| 07/30/2005 | CA2495497A1 Compositions for eliciting immune response and methods for using same |
| 07/28/2005 | WO2005068633A1 Differentiation regulating agent containing gene which regulating differentiation from stem cells into natural killer cells as effective ingredient |
| 07/28/2005 | WO2005068631A1 Ires functioning in plant |
| 07/28/2005 | WO2005068630A1 Double-stranded rna for interference |
| 07/28/2005 | WO2005068620A1 Method for the production of recombinant proteins |
| 07/28/2005 | WO2005068615A1 Method for inhibiting differentiation of pluripotent stem cell |
| 07/28/2005 | WO2005068614A2 Preparation of fibroblast-populated connective tissue substitute |
| 07/28/2005 | WO2005068613A1 Differentiation of cd34 positive cell to megakaryocyte and multiplication |
| 07/28/2005 | WO2005068612A2 Human hepatic progenitor cells and methods of use thereof |
| 07/28/2005 | WO2005068611A1 Method for obtaining a singular cell model capable of reproducing in vitro the metabolic idiosyncrasy of humans |
| 07/28/2005 | WO2005068610A1 Novel culture systems for ex vivo development |
| 07/28/2005 | WO2005067981A1 Gene therapy for tumor using minus-strand rna virus vector encoding immunostimulating cytokine |
| 07/28/2005 | WO2005067958A2 Methods and compositions for the inhibition of cathepsins |
| 07/28/2005 | WO2005067710A1 Non-human mammal model comprising heterologous nucleated cells-use for screening compounds |
| 07/28/2005 | WO2005067620A2 ANTIBODIES TO MAdCAM |
| 07/28/2005 | WO2005067500A2 Enhancement of immune responses |
| 07/28/2005 | WO2005067491A2 Toxin complex proteins and genes from xenorhabdus bovienii |
| 07/28/2005 | WO2005067477A2 Anti-human lymphotoxin alpha antibodies, compositions, methods and uses |
| 07/28/2005 | WO2005056780A3 Cell culture with nm23, cell culture media comprising nm23 and therapeutic use of cells cultured in the presence of nm23. |
| 07/28/2005 | WO2005054446A3 Use of polysulphated alginate in cellular matrices |
| 07/28/2005 | WO2005042581A3 Modified anti-cd52 antibody |
| 07/28/2005 | WO2005041942A9 Three-dimensional mammalian ovarian follicular cell and ovarian follicle culture systems in a biocompatible matrix |
| 07/28/2005 | WO2005041880A3 RhPV AS A MODEL FOR HPV-INDUCED CANCERS |
| 07/28/2005 | WO2005021730A3 Biodegradable polymer-ligand conjugates and their uses in isolation of cellular subpopulations and in cryopreservation, culture and transplantation of cells |
| 07/28/2005 | WO2005017163A3 Phenotypic knockout of cell-surface proteins |
| 07/28/2005 | WO2005009366A3 Restoring vascular function |
| 07/28/2005 | WO2005003300A3 Tissue scaffold having aligned fibrils, apparatus and method for producing same, and methods of using same |
| 07/28/2005 | WO2005001033A3 Tolerance induction and maintenance in hematopoietic stem cell allografts |
| 07/28/2005 | WO2003103597A3 Methods of diagnosing & treating diabetes and insulin resistance |
| 07/28/2005 | WO2003072035A8 Compositions and methods for the treatment of immune related diseases |
| 07/28/2005 | WO2002055010A3 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 07/28/2005 | US20050166283 Methods for simultaneous control of lignin content and composition, and cellulose content in plants |
| 07/28/2005 | US20050166282 Method and polynucleotides for determining translational efficiency of a codon |
| 07/28/2005 | US20050166281 Soybean cultivar 0509236 |
| 07/28/2005 | US20050166274 Compositions and methods for the diagnosis and treatment of tumor |
| 07/28/2005 | US20050166273 Rat model of diabetic nephropathy |
| 07/28/2005 | US20050166272 Double stranded RNA sequences for use as models in defining and determining sequence complement necessary for RNA interfering activity; wreck and check mutational analysis; blocking agents |
| 07/28/2005 | US20050165225 Novel cytokine isolated from an insect |
| 07/28/2005 | US20050165219 Related to the thymic stromal cotransporter subfamily; can be used as models for the development of and aid in the identification of therapeutic proteins that modulate transporter activity |
| 07/28/2005 | US20050164972 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |
| 07/28/2005 | US20050164971 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
| 07/28/2005 | US20050164948 Methods of treatment with prosaposin-derived peptides |
| 07/28/2005 | US20050164944 Promoting osteodifferentiation by coating a substrate with a solution of a synthetic peptide having -Ile-Ala residues folded in a beta-bend and mimics cell binding by collagen, incorporation into a biocompatible gel, exposure to cells; hard and soft tissue repair |
| 07/28/2005 | US20050164936 Antiinflammatory and antitumor agents; human T-cell leukemia/lymphoma virus and lymphadenopathy associated virus treatment; angiogenic- or hematopoiesis-related diseases; medical diagnosis |
| 07/28/2005 | US20050164926 Novel recombinant anticoagulant proteins |
| 07/28/2005 | US20050164917 Methods and means for producing proteins with predetermined post-translational modifications |
| 07/28/2005 | US20050164906 Inhibitors of the Mitogen Activated Protein Kinases (MAPKs) pathway activated by Ras/Raf complex using GILZ (glucocorticoid-Induced Leucine Zipper) protein related compounds as inhibitors of Raf/Ras-mediated signal transduction; anticarcinogenic agents |
| 07/28/2005 | US20050164392 Expression vector comprising adenoviral regulatory sequences for use as tool in enhancement of heterologous gene transfer and viral expression in cells |
| 07/28/2005 | US20050164391 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |
| 07/28/2005 | US20050164389 Nutrient broths and substrate for culturing mammalian stem cell tissue; tissue engineering and heterologous gene expression in fish bioreactors |
| 07/28/2005 | US20050164388 Method of isolating epithelial cells, method of preconditioning cells, and methods of preparing bioartificial skin and dermis with the epithelial cells and preconditioned cells |
| 07/28/2005 | US20050164387 Propagating lymphocytic cells without using large excesses of peripheral blood mononuclear cells (PBMC) or epstein barr virally-transformed lymphoblastoid cells (LCL); immunotherapy |
| 07/28/2005 | US20050164385 Embryonic stem cells having genetic modifications |
| 07/28/2005 | US20050164384 Methods for regulating differentiation of neural cells and uses thereof |
| 07/28/2005 | US20050164383 Undifferentiated progenitor cells invitro differentiation into somatic cell tissues; transplantation and treatment of congenital disorders |
| 07/28/2005 | US20050164382 Differentiation protocol for making human cardiomyocytes |
| 07/28/2005 | US20050164381 Pluripotent human progenitor cell culture for use tool in generating animal model for study of cell proliferative disorders |
| 07/28/2005 | US20050164380 Stem cell culture medium and method of using said medium and the cells |
| 07/28/2005 | US20050164379 Stable cell lines expressing HERG1a and HERG1b |
| 07/28/2005 | US20050164378 Using schwann cells as tools to establish propagating colonies of basal membranes muscles tissue; regenerative medicine; tissue engineering |
| 07/28/2005 | US20050164377 Base material for culturing embryo stem cells and culture method |
| 07/28/2005 | US20050164366 Tissue plasminogen activator-like protease |
| 07/28/2005 | US20050164352 Immunoglobulin interleukin fusion for activating lymphoid precursor cells; treatment and prevention of infection |
| 07/28/2005 | US20050164341 Methods of purification of cytochrome p450 proteins and of their crystallizing |
| 07/28/2005 | US20050164323 Identifying modulators of protein kinase c for use as treatments of respiratory system disorders; antiasthmatic agents |
| 07/28/2005 | US20050164303 Specific-C-peptide assay method |
| 07/28/2005 | US20050164291 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/28/2005 | US20050164284 Immunoglobulin composition for detection of cell death regulatory proteins; diagnosing cardiovascular, tumor, diabetic and nervous system disorders |
| 07/28/2005 | US20050164279 Secreted and transmembrane polypetides and nucleic acids encoding the same |
| 07/28/2005 | US20050164266 Secreted and transmembrane polypeptides and nucleic acids encoding the same |